TZYM Related New Coverage
-
Cowen Starts Tranzyme (TZYM) at Outperform
-
JMP Securities Starts Tranzyme (TZYM) at Market Outperform, $8 Target
-
BMO Capital Starts Tranzyme (TZYM) at Outperform
-
UPDATE - Canaccord Genuity Initiates Coverage on Tranzyme (TZYM) with a Buy; Moving Right Along Into Phase 3 Development
-
Stifel Nicolaus Starts Tranzyme (TZYM) at Buy
-
Canaccord Genuity Starts Tranzyme (TZYM) at Buy
-
Citi Starts Tranzyme (TZYM) at Buy
-
Citi Starts Tranzyme (TZYM) at Buy
Back to TZYM Stock Lookup
